Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer

Clinical Cancer Research

Volumn 8, Issue 1, 2002, Pages 117-123

  Kang, John S ^a   Mohler, James L ^a,b   Ornstein, David K ^a,b   Calvo, Benjamin F ^a,b   Caskey, Laura S ^a,b   Maygarden, Susan J ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 1;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE; GENETIC TRANSCRIPTION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR DYNAMICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; RNA ISOLATION; TRANSCRIPTION INITIATION;

ANNEXIN A1; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RNA, MESSENGER;

EID: 0036154940     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Laser capture microdissection
2. Loss of annexin I correlates with early onset of tumorigenesis in esophageal and prostate carcinoma
3. The genetics of cancer-a 3D model
4. An approach for proteomic analysis of microdissected human tumors
5. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines
6. Molecular profiling of clinical tissue specimens: Feasibility and applications
7. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity
8. Lipocortin-1: Cellular mechanisms and clinical relevance
9. Lipocortin 1 in apoptosis: Mammary regression
10. The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortintransduces the proliferating signal of the hepatocyte growth factor
11. Annexin I modulates cell functions by controlling intracellular calcium release
12. Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues
13. Application of avidin-biotin complex technique to the localization of estradiol receptor in target tissues using monoclonal antibody
14. Immunocytochemistry is automated: Development of a robotic workstation based upon capillary action principle
15. Intraductal dysplasia: A premalignant lesion of the prostate
16. Architectural patterns high-grade prostatic intraepithelial neoplasia
17. A threshold selection method from gray level histograms
18. Immunohistochemical quantification of androgen receptor using color video image analysis
19. Down regulation of β4 integrin subunit in prostate carcinoma and prostatic intraepithelial neoplasia
20. Real time quantitative PCR
21. Clinical evolution of prostatic intraepithelial neoplasia
22. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: A model for prostate cancer
23. Allelic loss in locally metastatic, multisampled prostate cancer
24. CG island methylation changes near the GSTPi gene in prostatic intraepithelial neoplasia
25. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo
26. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down regulates bcl-2 expression in LNCaP cells
27. The annexin protein lipocortin I regulates the MAPK/ERK pathway
28. Activation of extracellular signal-regulated kinase in human prostate cancer
29. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21
30. Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma
31. Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer
32. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization
33. CG island methylation changes near the GSTPi gene in prostatic carcinoma cells detected using the polymerase chain reaction: A new prostate cancer biomarker
34. Methylation of the CD44 metastasis suppressor gene in human prostate cancer
35. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B
36. Inactivation of CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
37. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers
38. P16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells
39. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells